To Our New Jersey Life Sciences Community:
Welcome to another edition of the Weekender.
It’s been an important week at BioNJ…one of those where we just cannot contain our excitement! (Actually to be honest, they are all pretty much like that!!!) What has us particularly excited about this week though, is that FDA Commissioner Dr. Stephen Ostroff and Dr. Bill Hait, Global Head, R&D at Janssen, J&J will participate in a Fireside Chat at our CEO Summit on October 9. Click here for details.
Meanwhile we are grateful to our Immediate Past Chairman Dr. Francois Nader who penned an op-ed published by The Star-Ledger explaining why it is imperative to ensure that Congress supports a patent system which protects innovation…and Patients…and the position of the U.S. as the world’s leader in medical innovation. Click here to review.
BioNJ applauds the U.S. House of Representatives for passing the Safe and Accurate Food Labeling Act this week with a solidly bipartisan vote. See the story herein for additional detail. We believe this legislation represents a reasonable way to ensure that consumers have access to the information they want while avoiding the complications which would be created by a patchwork of different state level food labeling laws.
Meanwhile we were so pleased at the report that “the pharmaceutical sector in Central New Jersey is seeing renewed growth”… and the shuffling of big pharma has subsided and resulted in “entrepreneurial former employees who have sparked a wave of new start-ups.” The result is that this market was deemed one of the most improved real estate markets in the country for Q2 2015, up 100 percent, driven by the pharmaceutical and communications sectors. See below for the full story.
In other good news, it was reported this week that in 2014, 100 Indian firms invested over $15 billion across all 50 states in the U.S. creating more than 91,000 jobs, according to a report by the audit and consultancy firm Confederation of Indian Industry and BioNJ Member Grant Thornton. New Jersey was second in job creation with 9,300 jobs. The jobs created are mainly in IT and telecom (40%) with 14% in pharmaceuticals and healthcare. See below for the full story.
Click here for this week’s Weekender.